Showing results (21-30 of 59) with videos related to
Sort By:
Pageof 6
Cancer Management and Research|November 23, 2022
Real-World Outcomes and Prognostic Factors Among Patients with Advanced Non-Small Cell Lung Cancer and High PD-L1 Expression Treated with Immune Checkpoint Inhibitors as First-Line TherapyWenzhen Ge, Ning Wu, Jessica J Jalbert, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 4, 2024
Lung Cancer Survivorship: Physical, Social, Emotional, and Medical Needs of NSCLC SurvivorsMelinda L Hsu, Matthew Z Guo, Sarah Olson, et al.Lung Cancer (Amsterdam, Netherlands)|February 19, 2017
Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC)Vincent K Lam, Søren M Bentzen, Pranshu Mohindra, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of lifeS Z Hazell, W Fu, C Hu, et al.Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infectionKatherine A Scilla, Dan P Zandberg, Søren M Bentzen, et al.The Oncologist|May 24, 2017
Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality TherapyKatherine A Scilla, Søren M Bentzen, Vincent K Lam, et al.JAMA Oncology|November 19, 2020
Nonpharmacological Interventions for Managing Breathlessness in Patients With Advanced Cancer: A Systematic ReviewArjun Gupta, Ramy Sedhom, Ritu Sharma, et al.Journal of Geriatric Oncology|September 20, 2020
Toxicity and survival outcomes in older adults receiving concurrent or sequential chemoradiation for stage III non-small cell lung cancer in Alliance trials (Alliance A151812)Ronald J Maggiore, David Zahrieh, Ryan P McMurray, et al.BMC Cancer|April 21, 2020
Hospitalization and definitive radiotherapy in lung cancer: incidence, risk factors and survival impactSarah Z Hazell, Nicholas Mai, Wei Fu, et al.JAMA Network Open|April 17, 2024
Unmet Needs, Quality of Life, and Financial Toxicity Among Survivors of Lung CancerMelinda L Hsu, Mary C Boulanger, Sarah Olson, et al.Pageof 6